DK2722331T3 - Pyrroloquinolinquinondinatriumsaltkrystal og fremgangsmåde til fremstilling af samme - Google Patents

Pyrroloquinolinquinondinatriumsaltkrystal og fremgangsmåde til fremstilling af samme

Info

Publication number
DK2722331T3
DK2722331T3 DK12800143.5T DK12800143T DK2722331T3 DK 2722331 T3 DK2722331 T3 DK 2722331T3 DK 12800143 T DK12800143 T DK 12800143T DK 2722331 T3 DK2722331 T3 DK 2722331T3
Authority
DK
Denmark
Prior art keywords
making
same
disodium salt
salt crystal
pyrroloquinoline quinone
Prior art date
Application number
DK12800143.5T
Other languages
English (en)
Inventor
Kazuto Ikemoto
Hitoshi Sakamoto
Original Assignee
Mitsubishi Gas Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Gas Chemical Co filed Critical Mitsubishi Gas Chemical Co
Application granted granted Critical
Publication of DK2722331T3 publication Critical patent/DK2722331T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/66Preparation of oxygen-containing organic compounds containing the quinoid structure

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
DK12800143.5T 2011-06-16 2012-06-15 Pyrroloquinolinquinondinatriumsaltkrystal og fremgangsmåde til fremstilling af samme DK2722331T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011134279 2011-06-16
PCT/JP2012/065303 WO2012173217A1 (ja) 2011-06-16 2012-06-15 ピロロキノリンキノンジナトリウム塩の結晶およびその製造方法

Publications (1)

Publication Number Publication Date
DK2722331T3 true DK2722331T3 (da) 2017-11-20

Family

ID=47357196

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12800143.5T DK2722331T3 (da) 2011-06-16 2012-06-15 Pyrroloquinolinquinondinatriumsaltkrystal og fremgangsmåde til fremstilling af samme

Country Status (9)

Country Link
US (1) US9174983B2 (da)
EP (1) EP2722331B1 (da)
JP (1) JPWO2012173217A1 (da)
CN (1) CN103619842B (da)
DK (1) DK2722331T3 (da)
ES (1) ES2651238T3 (da)
NO (1) NO2722331T3 (da)
PL (1) PL2722331T3 (da)
WO (1) WO2012173217A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9163014B2 (en) 2009-07-16 2015-10-20 Mitsubishi Gas Chemical Company, Inc. Crystals of pyrroloquinolinequinone sodium salts
CN102942567B (zh) * 2012-11-09 2017-02-08 诸城市浩天药业有限公司 吡咯并喹啉醌的二钠盐结晶
MA39715A (fr) * 2014-04-16 2015-10-22 Anthem Biosciences Private Ltd Formes polymorphes de l'acide 4,5-dihydro-1h-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylique et de son sel de disodium, procédé de préparation desdites formes polymorphes et leur utilisation
CN107207494B (zh) * 2015-01-19 2020-01-21 三菱瓦斯化学株式会社 溶解性高的丙酮加成吡咯喹啉醌盐
WO2017050171A1 (zh) 2015-09-25 2017-03-30 浙江海正药业股份有限公司 吡咯并喹啉醌钠盐的晶型及其制备方法和用途
JP6769705B2 (ja) * 2015-11-30 2020-10-14 株式会社協和 胎盤抽出物の製造方法
EP3480197B1 (en) * 2016-06-29 2024-04-03 Mitsubishi Gas Chemical Company, Inc. Pyrroloquinone quinone monosodium, method for manufacturing same, and composition including same
KR102120670B1 (ko) * 2019-01-03 2020-06-10 주식회사 누베파마 돌연변이 균주를 이용한 항산화 물질 생산 방법
CN112125899B (zh) * 2019-06-24 2023-01-03 浙江可明生物医药有限公司 吡咯并喹啉醌二钠盐结晶、其制备方法及包含其的组合物
CN115716825A (zh) * 2021-08-24 2023-02-28 浙江医药股份有限公司新昌制药厂 吡咯并喹啉醌二钠盐结晶、其制备方法及包含其的组合物
CN117327069B (zh) * 2023-09-27 2024-04-30 山东原力泰医药科技有限公司 吡咯并喹啉醌二钠盐晶型及其制备方法和应用
CN117777147A (zh) * 2024-02-23 2024-03-29 内蒙古金达威药业有限公司 一种吡咯并喹啉醌二钠盐的晶型及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07113024B2 (ja) 1986-04-17 1995-12-06 三菱瓦斯化学株式会社 ピロロキノリンキノンの精製方法
JP2751183B2 (ja) 1988-02-26 1998-05-18 三菱瓦斯化学株式会社 ピロロキノリンキノンの製造方法
JP2692167B2 (ja) * 1988-09-01 1997-12-17 三菱瓦斯化学株式会社 ピロロキノリンキノン類の回収・精製方法
JP3475969B2 (ja) 1993-08-27 2003-12-10 大日本インキ化学工業株式会社 共重合体樹脂エマルジョン、その製造方法及び防湿加工用組成物
NZ519984A (en) * 2000-01-07 2004-03-26 Transform Pharmaceuticals Inc High-throughput formation, identification, and analysis of diverse solid-forms
US7276514B2 (en) 2002-05-15 2007-10-02 Charitable Leadership Foundation - Medical Technology Acceleration Program Pyrroloquinoline quinone drugs for treatment of cardiac injury and methods of use thereof
JP2007269769A (ja) 2006-03-10 2007-10-18 Ultizyme International Ltd 神経変性疾患関連蛋白質凝集線維化抑制剤
US9163014B2 (en) 2009-07-16 2015-10-20 Mitsubishi Gas Chemical Company, Inc. Crystals of pyrroloquinolinequinone sodium salts
JPWO2011055796A1 (ja) * 2009-11-06 2013-03-28 三菱瓦斯化学株式会社 ピロロキノリンキノンのフリー体
JP2011098911A (ja) 2009-11-06 2011-05-19 Mitsubishi Gas Chemical Co Inc ピロロキノリンキノン粉体
JP2011246442A (ja) 2010-04-28 2011-12-08 Rohto Pharmaceutical Co Ltd 光老化抑制剤および皮膚菲薄化抑制剤

Also Published As

Publication number Publication date
US20140128609A1 (en) 2014-05-08
EP2722331A4 (en) 2014-11-05
CN103619842B (zh) 2016-06-22
EP2722331A1 (en) 2014-04-23
WO2012173217A1 (ja) 2012-12-20
EP2722331B1 (en) 2017-09-06
PL2722331T3 (pl) 2018-02-28
NO2722331T3 (da) 2018-02-03
ES2651238T3 (es) 2018-01-25
JPWO2012173217A1 (ja) 2015-02-23
US9174983B2 (en) 2015-11-03
CN103619842A (zh) 2014-03-05

Similar Documents

Publication Publication Date Title
DK2722331T3 (da) Pyrroloquinolinquinondinatriumsaltkrystal og fremgangsmåde til fremstilling af samme
DK3223284T3 (da) Fremgangsmåde til dannelse og opretholdelse af højydelses-frc
DK2739293T3 (da) Fremgangsmåder og sammensætninger til frembringelse af vaccinavirus
DK2718404T3 (da) Fremgangsmåde til fremstilling af flydende carbonhydrider
DK2718403T3 (da) Fremgangsmåde til fremstilling af flydende carbonhydrid
DK3824991T3 (da) Fremgangsmåde til forberedelse af lithiumsulfat
DK2776833T3 (da) Cobinder-understøttet testfremgangsmåde
DK2768796T3 (da) Fremgangsmåde til fremstilling af quinolin-derivater
BR112014007958A2 (pt) método
UY4116Q (es) Pulsera de reloj
DK3141548T3 (da) Fremgangsmåder og mellemprodukter til fremstilling af azaindoler
DK2732131T3 (da) Positioneringsfremgangsmåde
BR112014001237A2 (pt) método
BR112014001765A2 (pt) método
EP2918585A4 (en) Pyrroloquinoline-DINATRIUMSALZKRISTALL
ZA201503159B (en) Small crystal ferrierite and method of making the same
EP2800128A4 (en) PROCESS FOR PRODUCING A CRYSTALLINE FILM OF GA2O3
DK2787799T3 (da) Plade med indlejret komponent og fremgangsmåde til fremstilling af samme og pakke med plade med indlejret komponent
DK2785801T4 (da) Fremgangsmåde til formindskelse af isdannelse på et underlag
GB2498072B (en) Display device and method for manufacturing of the same
DK2880084T3 (da) Fremgangsmåde til klæbning med tynde klæbestoflag
DK3357830T3 (da) Beholderlukning og fremgangsmåde til fremstilling af samme
DK2731847T3 (da) Holdetidberegningsmodul
DK2701707T3 (da) Fremgangsmåde til behandling af dyskinesi
DK2714729T3 (da) Midler og fremgangsmåder til diagnosticering og behandling af multipel sklerose